The pharmaceutical industry faces diverse challenges, ranging from drug delivery to design optimization of equipment to resolving scale-up problems. Dealing with increasing raw material costs and decreasing time-to-market expectations create major issues in the development process.
How can engineering simulation help you address these challenges effectively?
Recently, the United States Congress, the US Food & Drug Administration (FDA) and the European Parliament have all publicly recognized the value of engineering simulation for demonstrating product performance and gaining regulatory approval. These bodies also acknowledge the ability of modeling to perform in silico clinical trials.
ANSYS has been dedicated to developing modeling methodologies that are highly relevant for the pharmaceutical industry. This seminar will provide an overview of ANSYS capabilities and application of our tools in healthcare, including the development of drug delivery devices and the optimization of mixing processes and other unit operations, as well as the current regulatory pathway for computational modeling.
You will also get the chance to observe a digital systems model of an insulin pump with embedded software for displays and controls, 3-D physics, and lumped parameter modeling.